Dr. Michael Diaz, MD

Dr. Diaz practices at BayCare St. Anthony's Hospital in Saint Petersburg, Florida, part of BayCare Health System.

Dr. Diaz's NPI, 1871574186, was assigned on November 14, 2005. Dr. Diaz graduated from University Of Kentucky College Of Medicine in 1999. Dr. Diaz holds Florida license ME84878.

Dr. Diaz's primary practice is BayCare St. Anthony's Hospital, at 1200 Seventh Ave N, Saint Petersburg, FL 33705 in Pinellas County. The practice phone is (727) 825-1100.

Dr. Diaz's primary practice is BayCare St. Anthony's Hospital in Saint Petersburg, Florida, part of BayCare Health System. Dr. Diaz is also affiliated with Orlando Health Bayfront Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Diaz to 3 more hospitals, 1 behavioral health center, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diaz practices, 8 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Diaz's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Diaz is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Diaz's licenses on file in 2 states: Florida and Virginia.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Diaz treats.

CMS data shows 110,921 Medicare services from Dr. Diaz across 41 procedure codes in 2024, for 552 Medicare patients. Medicare paid $280,587 for them.

CMS counts 552 Medicare patients who saw Dr. Diaz in 2024. The largest group is 65 to 74, with 234 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diaz's median patient age at 66, with 64% women.

In 2024, Dr. Diaz wrote 723 Medicare Part D claims for 246 patients. 75% of them were for generic drugs. CMS names the drug for 416 of them, across 18 drugs with 11 or more claims each, at $664,080 in total drug cost. In 2023, CMS named 569 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Diaz for performance year 2024, reported as part of a group. Dr. Diaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Diaz, published from 2020 to 2021. 2020 was the busiest year, with 4. The most frequent topics are COVID-19, Pandemics and SARS-CoV-2. Dr. Diaz's most frequent co-authors are Saif U. Zaman, MD, Travis Scott Henry, MD and Michael Douglas Hope, MD.

CMS Open Payments shows 1,265 general payments to Dr. Diaz from 108 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $3,246.

Dmand AI lists 1 award for Dr. Diaz, most recently CMS Stage 1 EHR in 2014.

Dr. Diaz graduated from University Of Kentucky College Of Medicine in 1999. Dr. Diaz is a member of ASCO.

Dr. Diaz is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.